Ozempic Could Have a New Multibillion-Dollar Market Opportunity. Is Novo Nordisk Stock a No-Brainer Buy?

Ozempic has reached a level of popularity that few prescription medications ever attain. Although the drug is officially approved in the U.S. only for treating type 2 diabetes and cardiovascular risk reduction, it's prescribed frequently off-label for weight loss.